Abstract

Schizophrenia is a symptomatically heterogeneous disorder characterized by the presence of positive and negative symptoms, and variable impairment in community functioning. Given the diversity of symptom presentations and functioning associated with schizophrenia, one of the key challenges facing the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial was the selection of efficient assessment measures appropriate to a community-based effectiveness trial. This article describes the rationale for the measurement approach adopted for the trial, provides a brief overview of the selected measures, and describes the process of training assessment raters for a large and geographically dispersed study group.

Keywords

Schizophrenia (object-oriented programming)AntipsychoticClinical trialIntervention (counseling)PsychiatryRandomized controlled trialPsychologyMedicineClinical psychologyInternal medicine

Affiliated Institutions

Related Publications

Publication Info

Year
2003
Type
article
Volume
29
Issue
1
Pages
33-43
Citations
109
Access
Closed

External Links

Citation Metrics

109
OpenAlex

Cite This

M S Swartz, Diana O. Perkins, T. Scott Stroup et al. (2003). Assessing Clinical and Functional Outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial. Schizophrenia Bulletin , 29 (1) , 33-43. https://doi.org/10.1093/oxfordjournals.schbul.a006989

Identifiers

DOI
10.1093/oxfordjournals.schbul.a006989